Open access
Open access
Powered by Google Translator Translator

Family Medicine

Brain fog can persist for months after COVID diagnosis.

28 Oct, 2021 | 10:13h | UTC

Assessment of Cognitive Function in Patients After COVID-19 Infection – JAMA Network Open

Commentaries:

Brain fog can persist 8 months after COVID diagnosis – CIDRAP

Brain fog in Covid-19 patients can persist for months, even in those who were not hospitalized, study finds – CNN

 


What COVID vaccines for young kids could mean for the pandemic.

28 Oct, 2021 | 10:15h | UTC

What COVID vaccines for young kids could mean for the pandemic – Nature

Related: FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children ages 5 to 11.

 


Retrospective cohort study: corticosteroid treatment linked to lower odds of surgical drainage among pediatric patients with retropharyngeal and parapharyngeal abscesses.

28 Oct, 2021 | 09:52h | UTC

Corticosteroids in the Treatment of Pediatric Retropharyngeal and Parapharyngeal Abscesses – Pediatrics

 


RCT: Extended follow-up of local steroid injection for carpal tunnel syndrome.

28 Oct, 2021 | 09:46h | UTC

Extended Follow-up of Local Steroid Injection for Carpal Tunnel Syndrome: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


Review: Genome sequencing as a diagnostic test.

28 Oct, 2021 | 09:42h | UTC

Genome sequencing as a diagnostic test – Canadian Medical Association Journal

 


Breakthrough infections occur in those with lower antibody levels.

27 Oct, 2021 | 01:45h | UTC

Breakthrough Infections Occur in Those with Lower Antibody Levels, Israeli Study Shows – NIH Director’s Blog

Original study: Covid-19 Breakthrough Infections in Vaccinated Health Care Workers – New England Journal of Medicine

 


Mix-and-match COVID vaccines ace the effectiveness test – “No need for brand loyalty”.

27 Oct, 2021 | 01:42h | UTC

Mix-and-match COVID vaccines ace the effectiveness test – Nature

Related:

Cohort Study: The effectiveness of heterologous AstraZeneca (AZ)/mRNA prime-boost vaccination was more significant (68%) compared to the effectiveness of homologous AZ/AZ vaccination (50%) against symptomatic Covid-19 infection in Sweden.

Should You Mix and Match Your Booster Shot?

Study evaluated several heterologous SARS-CoV-2 vaccine regimens; no efficacy data but there was increased antibody production on study days 15 and 29 after booster shots from Moderna and Pfizer.

A primer on what we know about mixing and matching Covid vaccines.

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination.

RCT: Safety and immunogenicity of heterologous vs. homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine.

Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination.

Heterologous Oxford–AstraZeneca and Moderna Vaccination induce increased levels of neutralizing antibody compared to 2 doses of Oxford–AstraZeneca.

Heterologous Oxford–AstraZeneca and BioNTech/Pfizer Vaccination induce increased levels of neutralizing antibody compared to 2 doses of Oxford–AstraZeneca.

[Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”.

Phase 2 RCT: Immunogenicity and reactogenicity of a Pfizer-BioNTech booster in patients that have received a single dose of AstraZeneca vaccine – “BNT162b2 (Pfizer) given as a second dose in individuals prime vaccinated with ChAdOx1-S (AstraZeneca) induced a robust immune response, with an acceptable and manageable reactogenicity profile”.

Lab study shows heterologous AstraZeneca/Pfizer vaccination produces strong immune response against SARS-CoV-2 Delta variant.

Lab study shows a heterologous AstraZeneca + Pfizer immunization strategy provides stronger immunogenicity against Covid compared to homologous AZ + AZ or Pfizer + Pfizer strategies.

RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects.

 


Heterologous AstraZeneca/Pfizer vaccination seems to be associated with increased effectiveness against Covid-19 compared to homologous Pfizer/Pfizer vaccination.

27 Oct, 2021 | 01:44h | UTC

Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination – Nature

Related:

Cohort Study: The effectiveness of heterologous AstraZeneca (AZ)/mRNA prime-boost vaccination was more significant (68%) compared to the effectiveness of homologous AZ/AZ vaccination (50%) against symptomatic Covid-19 infection in Sweden.

Should You Mix and Match Your Booster Shot?

Study evaluated several heterologous SARS-CoV-2 vaccine regimens; no efficacy data but there was increased antibody production on study days 15 and 29 after booster shots from Moderna and Pfizer.

A primer on what we know about mixing and matching Covid vaccines.

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination.

RCT: Safety and immunogenicity of heterologous vs. homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine.

Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination.

Heterologous Oxford–AstraZeneca and Moderna Vaccination induce increased levels of neutralizing antibody compared to 2 doses of Oxford–AstraZeneca.

Heterologous Oxford–AstraZeneca and BioNTech/Pfizer Vaccination induce increased levels of neutralizing antibody compared to 2 doses of Oxford–AstraZeneca.

[Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”.

Phase 2 RCT: Immunogenicity and reactogenicity of a Pfizer-BioNTech booster in patients that have received a single dose of AstraZeneca vaccine – “BNT162b2 (Pfizer) given as a second dose in individuals prime vaccinated with ChAdOx1-S (AstraZeneca) induced a robust immune response, with an acceptable and manageable reactogenicity profile”.

Lab study shows heterologous AstraZeneca/Pfizer vaccination produces strong immune response against SARS-CoV-2 Delta variant.

Lab study shows a heterologous AstraZeneca + Pfizer immunization strategy provides stronger immunogenicity against Covid compared to homologous AZ + AZ or Pfizer + Pfizer strategies.

RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects.

 

Commentary on Twitter

 


UEG Consensus on Functional Dyspepsia.

27 Oct, 2021 | 01:32h | UTC

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia – UEG Journal

 


Anticoagulants and diabetes agents are among the most frequent causes of emergency department visits attributed to medication harms.

27 Oct, 2021 | 01:15h | UTC

US Emergency Department Visits Attributed to Medication Harms, 2017-2019 – JAMA (link to abstract – $ for full-text)

Commentaries:

Number of emergency room visits for medication harms increases with age – MedicalResearch.com

Blood thinners, diabetes meds among top causes of drug-related ER visits – UPI

 


Systematic Review: Antibiotics for the treatment of COVID‐19 – “We are certain that risk of death in hospitalized COVID‐19 patients is not reduced by treatment with azithromycin after 28 days”.

26 Oct, 2021 | 02:07h | UTC

Antibiotics for the treatment of COVID‐19 – Cochrane Library

 

Commentary on Twitter

 


Podcast: Atopic Dermatitis Pearls.

27 Oct, 2021 | 01:01h | UTC

Atopic Dermatitis Pearls – The Cribsiders

 


[Press release – not published yet] Moderna says its COVID vaccine produced a strong antibody response for kids 6 to 11.

26 Oct, 2021 | 02:06h | UTC

Press release: Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age

Commentary: Moderna says new data supports its COVID vaccine for kids 6 to 11 – NPR

 


Infection with Covid-19 carries a much higher risk of developing neurological complications than Covid-19 vaccines.

26 Oct, 2021 | 02:04h | UTC

News Release: Infection with Covid-19 carries a much higher risk of developing neurological complications than a vaccine, says new study – University of Nottingham

Original Study: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection – Nature Medicine

Commentaries:

Covid: Vaccine study links virus to rare neurological illness – BBC

Expert reaction to study looking at rare neurological complications after SARS-CoV-2 infection and COVID-19 vaccination – Science Media Centre

 

Commentary on Twitter

 


What It Means To Be Fully Vaccinated.

26 Oct, 2021 | 01:57h | UTC

What It Means To Be Fully Vaccinated – Think Global Health

 


Adult-Onset Type 1 Diabetes: Current Understanding and Challenges.

26 Oct, 2021 | 01:47h | UTC

Adult-Onset Type 1 Diabetes: Current Understanding and Challenges – Diabetes Care

Related:

ADA Consensus Report: The Management of Type 1 Diabetes in Adults.

Guideline: ADA 2021 Standards of Medical Care in Diabetes

 


Association of a sweetened beverage tax with reduction in soda consumption in high school students.

26 Oct, 2021 | 01:30h | UTC

Association of a Sweetened Beverage Tax With Soda Consumption in High School Students – JAMA Pediatrics (free for a limited period)

Commentary: Philadelphia’s ‘soda tax’ cut the number of sugar-sweetened beverages high school students drank per week by 30%, study finds – News Break

Related:

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study.

UK National Food Strategy: Tax sugar and salt and prescribe veg, report says.

Perspective – Sugar-sweetened beverage taxes: Lessons to date and the future of taxation

Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption

Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake

Cochrane Review: Environmental Interventions to Reduce the Consumption of Sugar‐sweetened Beverages and Their Effects on Health

Study: Snack Tax May be More Effective than a Sugary Drink Tax to Tackle Obesity

Sugar Tax: Why Health Experts Want it But Politicians and Industry are Resisting

The Effect of Food Price Changes on Consumer Purchases: A Randomized Experiment

Taxes on Sugar-Sweetened Beverages Associated with Reduced Consumption

Soda Tax Linked to a 50 Percent Reduction in Sugary Drink Consumption

AAP/AHA Policy Statement: Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents

Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization

The Lancet taskforce on NCDs and economics

To improve global health, tax the things that are killing us – Financial Times

Reducing cardiovascular disease burden through targeted dietary policies

Fiscal policies for the prevention of diseases

The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities

 

Commentary on Twitter

 


RCT: The association of Varenicline and Nicotine patch was not better than Varenicline alone to increase smoking abstinence; there was also no difference between 24-week vs. 12-week treatment courses in abstinence rates.

24 Oct, 2021 | 23:45h | UTC

Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Is There a Role for Combined Use of Varenicline and Nicotine Patch or Extended Treatment Duration to Enhance Smoking Cessation? – JAMA (free for a limited period)

Commentary: Varenicline Combo, Extension No Better for Quitting Smoking – HealthDay

 

Commentary on Twitter

 


Perspective | The flawed science of antibody testing for SARS-CoV-2 immunity.

22 Oct, 2021 | 10:30h | UTC

The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity – JAMA

 


[Press release – not published yet] A phase 3 trial with more than 10,000 participants showed a booster dose of the Pfizer/BioNTech vaccine had an efficacy of 95.6% against disease; there were 5 cases in the booster group and 109 cases in the non-boosted group, not classified according to severity.

22 Oct, 2021 | 10:34h | UTC

Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine

Commentary: Booster dose of Pfizer/BioNTech coronavirus vaccine shows 95.6% efficacy in Phase 3 trial, companies say – CNN

 

Commentaries on Twitter

 


Cluster RCT: Increasing the dietary sources of calcium and protein (by providing additional milk, yogurt, and cheese) reduced hip fractures and falls in older adults in residential care.

22 Oct, 2021 | 10:21h | UTC

Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care: cluster randomised controlled trial – The BMJ

News release: Increasing dairy intake reduces falls and fractures among older care home residents – British Medical Journal

 

Commentary on Twitter

 


M-A: Risk factors for poor prognosis in children and adolescents with COVID-19.

22 Oct, 2021 | 10:24h | UTC

Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis – EClinicalMedicine

 


RCT: Mirtazapine not better than placebo for the treatment of agitation in people with dementia and was possibly associated with increased mortality (7 vs.1 deaths, difference not statistically significant; p=0·065).

22 Oct, 2021 | 10:19h | UTC

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial – The Lancet

Commentary: Common antidepressant should no longer be used to treat people with dementia – University of Exeter

 


Radiotherapy: Clinical pearls for primary care.

22 Oct, 2021 | 10:12h | UTC

Radiotherapy: Clinical pearls for primary care – Canadian Family Physician

 


Podcast: Managing Pediatric Hypertension in Your Primary Care Clinic.

22 Oct, 2021 | 10:10h | UTC

#36: Off the Cuff – Managing Pediatric Hypertension in Your Primary Care Clinic – The Cribsiders

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.